Gelonghui, March 29丨Tibet Pharmaceutical (600211.SH) announced that the company and its subsidiary, Tibet Nordicom Pharmaceutical Co., Ltd. received 86,202,742 yuan in industrial development support funds from the Shannan Happy Home Construction Administration on March 29, 2024, accounting for 10.76% of the company's most recent (2023) audited net profit attributable to shareholders of listed companies.
西藏药业(600211.SH):获得产业扶持资金8620万元
Tibet Pharmaceutical (600211.SH): Received 86.2 million yuan in industrial support funds
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.